Company intelligence / Profile preview

Agibot Medical Technology

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Commercial

Overview

Agibot develops and commercializes advanced, AI-powered surgical and general-purpose humanoid robots. Its medical technology division focuses on intelligent, minimally invasive surgical devices designed to improve clinical outcomes. The company is rapidly scaling production of its industrial and healthcare robot lines, with over a thousand units produced by end of 2024. It holds patents related to robotic arms for surgery and is expanding internationally through joint ventures and academic collaborations[3][4][9].

Therapeutic areas: Other
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Ministry of Digital Development & Aerospace Industry (Kazakhstan)ewpartners (private equity fund)Qazaqstan Investment Corporation

Beyond the preview

Go deeper on Agibot Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agibot Medical Technology.

Explore the full profile